Non-small cell lung cancer (NSCLC) tumors contain large percentages of T cells (25–46% of the CD45+ fraction), many expressing tumor antigen-specific T cell receptors (TCRs) [1,2]. This evidence concerns the gene PTPRC and non-small cell lung carcinoma.